BioMarin (BMRN) is up 16.7%, or $8.66 to $60.61.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BMRN:
- BioMarin Pharmaceutical (BMRN) and Amicus (FOLD) Stocks Soar on a $5B Acquisition Agreement
- BioMarin to Acquire Amicus, Expanding Rare Disease Portfolio
- Amicus jumps 30% to $14.16 after buyout offer from BioMarin
- BioMarin sees Amicus acquisition accretive to EPS in first year post close
- BioMarin to acquire Amicus for $14.50 per share in cash, or $4.8B